Studies have demonstrated that the inhibition of aberrant miR-133a by lovastatin prevents endothelial dysfunction by targeting GTP cyclohydrolase 1, a critical enzyme for eNOS uncoupling in endothelial dysfunction [39]. Here, GCH1 is linked to endothelial dysfunction.